Sergio Santoro

Dr. Sergio Santoro


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2012 in Annals of Surgery
Verified
Journal Article
Closed access
SSSergio Santoro
Sergio Santoro
LCLuis Carlos Castro
Luis Carlos Castro
MVManoel Carlos Prieto MD Velhote
Manoel Carlos Prieto MD Velhote
CMCarlos Eduardo Md Malzoni
Carlos Eduardo Md Malzoni
SKSidney Md Klajner
Sidney Md Klajner
MSMarco Aurélio Santo
Marco Aurélio Santo
Objective: To present 5-year results of sleeve gastrectomy (SG) with transit bipartition (TB) as a metabolic intervention for obesity. Background: Recent data suggest that high glycemic index foods may lead to a hormonally hyperactive proximal gut and a hypoactivate distal gut, which are linked to metabolic syndrome. TB was designed to counterbalance these effects. Methods: A total of 1020 obese patients with body mass index (BMI) ranging from 33 to 72 Kg/m2 underwent SG and TB (SG + TB). TB creates a gastroileal anastomosis in the antrum after the SG; nutrient transit is maintained in the duodenum, avoiding blind loops and minimizing malabsorption. The stomach retains 2 outflow pathways. A lateral enteroanastomosis connects both segments at 80 cm proximal to the cecum. Results: Adequate follow-up data were collected in 59.1% of patients from 4 months to 5 years. The average percent of excess BMI loss was 91%, 94%, 85%, 78%, and 74% in the first, second, third, fourth, and fifth year, respectively. Patients experienced early satiety and major improvement in presurgical comorbidities, including diabetes (86% in remission), following surgery. Two deaths occurred (0.2%). Other surgical complications occurred in 6% of patients. Signs of malabsorption were rare. Conclusions: SG + TB is a simple procedure that results in rapid weight loss and remission or major improvement of comorbidities. Strictly aiming at physiological correction, TB avoids prostheses, narrow anastomoses, excluded segments, and malabsorption. Weight and comorbidities are much improved. Diabetes is improved without duodenal exclusion. TB is an excellent complement to an SG.

1 October 2006 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
SSSergio Santoro
Sergio Santoro
CMCarlos Malzoni
Carlos Malzoni
MVManoel C P Velhote
Manoel C P Velhote
FMFábio Q Milleo
Fábio Q Milleo
MSMarco Santo
Marco Santo
JMJoão G Maksoud
João G Maksoud

15 December 2007 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
SSSergio Santoro
Sergio Santoro
FMFábio Quirilo Milleo
Fábio Quirilo Milleo
CMCarlos Eduardo Malzoni
Carlos Eduardo Malzoni
SKSidney Klajner
Sidney Klajner
PBPedro C. M. Borges
Pedro C. M. Borges
RARoberto Ferreira Artoni
Roberto Ferreira Artoni

1 November 2007 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
SSSergio Santoro
Sergio Santoro

1 September 2014 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
SSSergio Santoro
Sergio Santoro
ALArnaldo Lacombe
Arnaldo Lacombe
CACaio Gustavo Gaspar de Aquino
Caio Gustavo Gaspar de Aquino
CMCarlos Eduardo Malzoni
Carlos Eduardo Malzoni
Objective Sleeve gastrectomy is the fastest growing surgical procedure to treat obesity in the world but it may cause or worsen gastroesophageal reflux disease. This article originally aimed to describe the addition of anti-reflux procedures (removal of periesophageal fats pads, hiatoplasty, a small plication and fixation of the gastric remnant in position) to the usual sleeve gastrectomy and to report early and late results. Methods Eighty-eight obese patients that also presented symptoms of gastroesophageal reflux disease were submitted to sleeve gastrectomy with anti-reflux procedures. Fifty of them were also submitted to a transit bipartition. The weight loss of these patients was compared to consecutive 360 patients previously submitted to the usual sleeve gastrectomy and to 1,140 submitted to sleeve gastrectomy + transit bipartition. Gastroesophageal reflux disease symptoms were specifically inquired in all anti-reflux sleeve gastrectomy patients and compared to the results of the same questionnaire applied to 50 sleeve gastrectomy patients and 60 sleeve gastrectomy + transit bipartition patients that also presented preoperative symptoms of gastroesophageal reflux disease. Results In terms of weight loss, excess of body mass index loss percentage after anti-reflux sleeve gastrectomy is not inferior to the usual sleeve gastrectomy and anti-reflux sleeve gastrectomy + transit bipartition is not inferior to sleeve gastrectomy + transit bipartition. Anti-reflux sleeve gastrectomy did not add morbidity but significantly diminished gastroesophageal reflux disease symptoms and the use of proton pump inhibitors to treat this condition. Conclusion The addition of anti-reflux procedures, such as hiatoplasty and cardioplication, to the usual sleeve gastrectomy did not add morbidity neither worsened the weight loss but significantly reduced the occurrence of gastroesophageal reflux disease symptoms as well as the use of proton pump inhibitors.

1 August 2015 in Annals of Surgery
Verified
Journal Article
Closed access
SSSergio Santoro
Sergio Santoro